zicronapine succinic acid (Jiangsu Nhwa Pharmaceutical)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namezicronapine succinic acid (Jiangsu Nhwa Pharmaceutical)
Drug Alias Namezicronapine succinate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D1 receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorDopamine D1 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A